The lab focus is to solve problems that limit the ability of cancer therapy to be used more effectively against deadly forms of pediatric cancers and adult cancers. We focus our research on pediatric tumors of the nervous system such as neuroblastoma and medulloblastoma, and bone metastases from different tumor origin.
Our research is balanced by a commitment to the value of basic and translational research. This effort is based on the integrated approach of single-cell technologies, computational modeling, and functional preclinical testing, directed at understanding the role of the tumor microenvironment in cancer development, tumor cell dissemination and cancer resistance.
Karolinska Institutet is one of the world’s foremost medical universities.The vision of Karolinska is to make a significant contribution to the improvement of human health; the mission is to conduct research and education and to interact with the community. As a university, Karolinska Institutet is Sweden’s single largest center of medical academic research and offers the country’s widest range of medical courses and programs. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Our lab research is funded by both internal and external funding through: